Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.

Insurers and self-funded employers are making significant changes to their GLP-1 drug coverage policies in 2025, reflecting the financial and operational challenges posed by the high-cost medications.

Results among Omada members taking GLP-1s for weight loss who entered into a discontinuation care track (n=63) showed that, on average, members were able to successfully maintain their weight 16 weeks ...

particularly given the low adherence rates and high cost of GLP-1s. To help employers, health plans, and pharmacy benefit managers deliver best-in-class outcomes with or without GLP-1 medications ...